Skip to content
Search

Latest Stories

Indian cancer researchers develop tablet to prevent cancer recurrence

The tablet is also touted to reduce the side effects of treatments like radiation and chemotherapy by a significant 50 per cent

Indian cancer researchers develop tablet to prevent cancer recurrence

The Tata Memorial Centre (TMC) in Mumbai, a leading cancer research and treatment centre in India, claims to have made a groundbreaking discovery in cancer treatment. After a decade of research, scientists and doctors at the institute have developed a tablet that could prevent the recurrence of cancer in patients.

This tablet is also touted to reduce the side effects of treatments like radiation and chemotherapy by a significant 50 per cent. The key focus of this discovery is the understanding of what happens after cancer treatment.


According to the Tata Memorial Centre (TMC) research, dying cancer cells release cell-free chromatin particles (cfChPs), fragments of chromosomes that can turn healthy cells into cancerous ones. Some of these particles may fuse with healthy chromosomes, leading to the formation of new tumours.

To tackle this problem, doctors administered pro-oxidant tablets containing resveratrol and copper (R+Cu) to rats. These tablets generate oxygen radicals that can destroy chromatin particles.

When taken orally, R+Cu produce oxygen radicals in the stomach, which are quickly absorbed into the bloodstream. These radicals then work to destroy cfChPs released in circulation, preventing the movement of cancer cells from one part of the body to another, known as metastases.

Additionally, the researchers claim that R+Cu can help prevent chemotherapy toxicity. The researchers, in their presentation, referred to this breakthrough as the "Magic of R+Cu."

Led by Prof Indraneel Mittra from the Translational Research Laboratory at TMC's Advanced Centre for Treatment, Research, and Education (ACTREC), the study involved implanting human breast cancer cells into mice to induce tumour formation.

After establishing tumours, the mice underwent various treatments, including chemotherapy, radiotherapy, or surgery. Notably, half of the mice received agents designed to deactivate or destroy cfChPs.

The focus on cfChPs arises from their potential role in the spread of cancer. After chemotherapy and radiotherapy, the researchers observed a significant increase in human DNA (cfChPs) and cancer proteins in the mice brains.

However, mice treated with cfChP-deactivating/destroying agents showed minimal presence of human cfChPs or cancer proteins in their brains.

The significance of these findings lies in the suggestion that cfChPs, containing cancer-causing genes, may travel through the bloodstream and enter healthy cells in different organs, contributing to the metastatic spread of cancer.

This challenges the traditional understanding of cancer metastasis and highlights the potential role of these released particles in initiating cancer in previously healthy cells.

Moreover, the study raises concerns about the unintended consequences of current cancer treatment practices. While chemotherapy and radiotherapy aim to eliminate primary tumour cells, the release of cfChPs from dying cells poses a potential threat.

These particles can travel to distant organs, instigating the formation of secondary tumours in otherwise healthy tissues. The researchers propose a shift in the perspective on cancer metastasis, urging clinicians to consider cfChPs as a potential culprit rather than attributing metastasis solely to migrating cancer cells.

This shift has critical implications for developing effective cancer treatment policies. Furthermore, the study advocates for the inclusion of drugs or agents that can deactivate or destroy cfChPs in cancer treatment protocols.

By targeting these particles, the researchers believe it is possible to mitigate the risk of metastatic spread.

This represents a potential breakthrough in enhancing the outcomes of cancer treatment, addressing not only the primary tumour but also the risk of secondary tumours arising from the release of cfChPs.

This cancer treatment breakthrough can be successful for the post-treatment of cancer-cured patients.

More For You

​Dilemmas of dating in a digital world

We are living faster than ever before

AMG

​Dilemmas of dating in a digital world

Shiveena Haque

Finding romance today feels like trying to align stars in a night sky that refuses to stay still

When was the last time you stumbled into a conversation that made your heart skip? Or exchanged a sweet beginning to a love story - organically, without the buffer of screens, swipes, or curated profiles? In 2025, those moments feel rarer, swallowed up by the quickening pace of life.

Keep ReadingShow less
sugary drinks and ice cream

Researchers from the UK and US analysed data from American households between 2004 and 2019

iStock

Global warming may drive higher consumption of sugary drinks and ice cream, study warns

Highlights:

  • Hotter days linked to greater intake of sugary drinks and frozen desserts
  • Lower-income households most affected, research finds
  • Climate change could worsen health risks linked to sugar consumption
  • Study based on 15 years of US household food purchasing data

Sugary consumption rising with heat

People are more likely to consume sugary drinks and ice cream on warmer days, particularly in lower-income households, according to new research. The study warns that climate change could intensify this trend, adding to health risks as global temperatures continue to rise.

Sugar consumption is a major contributor to obesity, diabetes, and cardiovascular disease, and has surged worldwide in recent decades. The findings, published in Nature Climate Change, suggest that rising heat could be nudging more people towards high-sugar products such as soda, juice and ice cream.

Keep ReadingShow less
Camellia Panjabi's cookbook elevates
vegetables from sides to stars

Camellia Panjabi (Photo: Ursula Sierek)

Camellia Panjabi's cookbook elevates vegetables from sides to stars

RESTAURATEUR and writer Camellia Panjabi puts the spotlight on vegetables in her new book, as she said they were never given the status of a “hero” in the way fish, chicken or prawns are.

Panjabi’s Vegetables: The Indian Way features more than 120 recipes, with notes on nutrition, Ayurvedic insights and cooking methods that support digestion.

Keep ReadingShow less
Spotting the signs of dementia

Priya Mulji with her father

Spotting the signs of dementia

How noticing the changes in my father taught me the importance of early action, patience, and love

I don’t understand people who don’t talk or see their parents often. Unless they have done something to ruin your lives or you had a traumatic childhood, there is no reason you shouldn’t be checking in with them at least every few days if you don’t live with them.

Keep ReadingShow less
HH Guruji performed the Dhwaja Ritual at Ambaji Temple

HH Guruji performed the Dhwaja Ritual at Ambaji Temple

Mahesh Liloriya

The holy town of Ambaji witnessed a spiritually significant day on Sunday as His Holiness Siri Rajrajeshwar Guruji, head of the International Siddhashram Shakti Centre, London, performed the Dhwaja ritual at the historic Ambaji Temple in Gujarat, one of the most revered Shakti Peeths of India.

Keep ReadingShow less